Rozh H Al-Mashhadi, Jacob F Bentzon, Lars P Tolbod: Tissue volume and activity mapping using total intensity projection of PET/CT images. Am J Nucl Med Mol Imaging 2019;9(1):1-11. (Full text, PDF)
Irina Velikyan, Philip Schweighöfer, Joachim Feldwisch, Johanna Seemann, Fredrik Y Frejd, Henrik Lindman, Jens Sörensen: Diagnostic HER2-binding radiopharmaceutical, [68Ga]Ga-ABY-025, for routine clinical use in breast cancer patients. Am J Nucl Med Mol Imaging 2019;9(1):12-23. (Full text, PDF)
Rustain Morgan, Bennett B Chin, Ryan Lanning: Feasibility of rapid integrated radiation therapy planning with follow-up FDG PET/CT to improve overall treatment assessment in head and neck cancer. Am J Nucl Med Mol Imaging 2019;9(1):24-29. (Full text, PDF)
Ashutosh Dash, Rubel Chakravarty: Radionuclide generators: the prospect of availing PET radiotracers to meet current clinical needs and future research demands. Am J Nucl Med Mol Imaging 2019;9(1):30-66. (Full text, PDF)
Ana de la Fuente, Stefan Kramer, Nicole Mohr, Stefanie Pektor, Benedikt Klasen, Nicole Bausbacher, Matthias Miederer, Rudolf Zentel, Frank Rösch: 68Ga[Ga]-, 111In[In]-oxine: a novel strategy of in situ radiolabeling of HPMA-based micelles. Am J Nucl Med Mol Imaging 2019;9(1):67-83. (Full text, PDF)
Rikke J Petersen, Nick S Nielsen, Helle H Johannesen, Adam E Hansen, Sofie Jespersen, Caroline J Arnbjerg, Johan Löfgren, Mette S Kjær, Mette R Clausen, Andreas Kjær, Susanne D Nielsen, Barbara M Fischer: PET/DW-MRI for evaluating treatment in chronic hepatitis C patients. Am J Nucl Med Mol Imaging 2019;9(1):84-92. (Full text, PDF)
Jadith Ziegler, Michelle Zalles, Nataliya Smith, Debra Saunders, Megan Lerner, Kar-Ming Fung, Maulin Patel, Jonathan D Wren, Florea Lupu, James Battiste, Rheal A Towner: Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment. Am J Nucl Med Mol Imaging 2019;9(1):93-109. (Full text, PDF)
